LACTOPRES:Study on the Effect of Dairy Peptides on Blood Pressure in Untreated Hypertensive Subjects.

This study has been completed.
Sponsor:
Collaborator:
Unilever R&D
Information provided by:
Wageningen University
ClinicalTrials.gov Identifier:
NCT00167869
First received: September 12, 2005
Last updated: May 23, 2008
Last verified: May 2008

September 12, 2005
May 23, 2008
June 2004
June 2005   (final data collection date for primary outcome measure)
Blood pressure
Same as current
Complete list of historical versions of study NCT00167869 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
LACTOPRES:Study on the Effect of Dairy Peptides on Blood Pressure in Untreated Hypertensive Subjects.
LACTOPRES:Study on the Effect of Dairy Peptides on Blood Pressure in Untreated Hypertensive Subjects.

Hypertension is an increasingly important medical and public health issue. Literature suggests that there may be a role for dairy foods in the prevention and treatment of hypertension. Recently, it has been suggested that several peptides in milk proteins could have blood pressure lowering properties. LACTOPRES is a randomised, double-blind parallel trial to assess the blood pressure effect of an increased intake of dairy peptides in humans.

Not Provided
Interventional
Phase 2
Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double-Blind
Primary Purpose: Prevention
Hypertension
Behavioral: dairy peptides
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
135
June 2005
June 2005   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • systolic blood pressure >= 140 mmHg
  • BMI between 18 and 32 kg/m2
  • apparently healthy

Exclusion Criteria:

  • antihypertensive medication
  • medically prescribed or slimming diet
  • lactating, pregnant
  • irregular pulse
Both
35 Years to 70 Years
Yes
Contact information is only displayed when the study is recruiting subjects
Netherlands
 
NCT00167869
METC-WU 04/04
Not Provided
Not Provided
Wageningen University
Unilever R&D
Principal Investigator: Frans J Kok, PhD Wageningen University - Division of Human Nutrition
Wageningen University
May 2008

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP